ELENA HIGH: Open Payments
NPI 1134806946 · CHARLOTTESVILLE, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,535 in 51 payments from 20 companies in 2025. Trend: 2023 $566 · 2024 $3,611 · 2025 $1,535
Food & beverage: $1,535
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $410 |
| EMD Serono, Inc. | 7 | $390 |
| Celgene Corporation | 5 | $94 |
| Novartis Pharmaceuticals Corporation | 3 | $64 |
| Genentech USA, Inc. | 2 | $63 |
| TG Therapeutics, Inc. | 2 | $63 |
| UCB, Inc. | 3 | $62 |
| ARGENX US, INC. | 2 | $54 |
| Alexion Pharmaceuticals, Inc. | 2 | $52 |
| Eisai Inc. | 2 | $46 |
Products named: QULIPTA, UBRELVY, ZEPOSIA, KESIMPTA, BRIUMVI, VYVGART HYTRULO, ULTOMIRIS, Leqembi.
Industry payments across VA — which companies pay providers there.
